Sustained Release of IL-2 Using an Injectable Hydrogel Prevents Autoimmune Diabetes
N. Nagy, G. Kaber, M. Kratochvil, H. Kuipers, S. Ruppert, K. Yadava, J. Yang, S. Heilshorn, A. Long, A. Pugliese, P. Bollyky
This paper develops an IL-2 hydrogel that prevents diabetes in NOD mice by sustained release and immune modulation.
bioRxiv · Mar 15, 2020 · PreprintImmunology